Biotech Values

[Whalatane]

MDGL / VKTX. ..Titan ...anything that raises Liver enzymes is a non starter as far as I'm concerned ...for the Hetero FH population ....we are already concerned about possible liver damage from the high intensity statins we are on.
From Science Direct ...quick copy ...did not read entire article
Treatment with low-moderate intensity statins is safe. By contrast, high intensity statin treatment may induce liver toxicity.

MGL3196 improves Liver enzymes ...as well as lowering surrogate CV risk markers .

I sold half my MDGL position after it was up 100% ......trading rule I have and try to stick with .
I'm hoping they will raise funds and the stock sells off before the Hetero FH data late Jan 2018 ...so I can add to what remains.

I'm not trying to "pump " this stock . I would like to read opposing views and debate the merits .
Dew had mentioned Enanta for NASH ...ok but I see no benefit in their drug for Hetero FH ...no dose related changes in Lipids

With MDGL you get improvement in Liver AND improvement in CV Lipids ....can anyone name another drug in development that does that ?
If so please cite
thx
Kiwi